Source: StemBioSys Blog

StemBioSys Blog CCN1 and the Bone Marrow Mesenchymal Stem Cell Niche

Matrix Biology's August 2022 edition includes a report entitled " Matrix-bound Cyr61/CCN1 is required to retain the properties of the bone marrow mesenchymal stem cell niche but is depleted with aging". The report is written by StemBioSys scientific advisor Milos Marinkovic, Ph.D., Assistant Professor in the Department of Comprehensive Dentistry at University of Texas Health at San Antonio. It is based on studies conducted with a team of scientists including StemBioSys CTO Travis Block, Ph.D. and StemBioSys founder and scientific advisor Xiao-Dong Chen, M.D., Ph.D., Professor in the Department of Comprehensive Dentistry at University of Texas Health at San Antonio.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Robert Hutchens's photo - President & CEO of StemBioSys

President & CEO

Robert Hutchens

CEO Approval Rating

90/100

Read more